Seongnam, South Korea

Myung-Hwa Kim

This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Curacle Co., Ltd., Gwangju Institute of Science and Technology, Korea Advanced Institute of Science and Technology. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myung-Hwa Kim. Retrieved from https://idiyas.com/inventor/myung-hwa-kim-dfd8fin1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 6.4

ph-index = 1


Location History:

  • Seongnam-si, KR (2022)
  • Seoul, KR (2022)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Myung-Hwa Kim: Innovator in Vascular Leakage Blockers

Introduction

Myung-Hwa Kim is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of vascular leakage blockers. With a total of 3 patents to his name, Kim's work is characterized by innovation and a focus on high-quality drug substances.

Latest Patents

Kim's latest patents include a crystalline form of a vascular leakage blocker compound. This invention relates to a crystalline form of (E)-methyl 6-((3S,8S,9S,10R,13S,14S,17R)-3-(((5S,6R)-5-acetoxy-6-(acetoxytnethyl)-5,6-dihydro-2H-pyran-2-yl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10.11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-yl)hept-5-enoate and a blood vessel leak blocker comprising the same. This novel crystalline form boasts high purity, excellent stability, and pharmaceutical reliability, making it advantageous for producing high-quality drug substances. Another significant patent is a preparation method of vascular leakage blockers with a high yield. This method is more productive and economical than conventional methods, utilizing an intermediate that effectively removes impurities generated during the reaction.

Career Highlights

Throughout his career, Myung-Hwa Kim has worked with esteemed organizations such as Curacle Co., Ltd. and the Gwangju Institute of Science and Technology. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical field.

Collaborations

Kim has collaborated with notable coworkers, including Koo Hyeon Ahn and Jung-In Pyo. Their combined expertise has further advanced the development of innovative pharmaceutical solutions.

Conclusion

Myung-Hwa Kim's contributions to the field of vascular leakage blockers highlight his innovative spirit and dedication to improving pharmaceutical quality. His patents and career achievements reflect a commitment to advancing medical science and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…